Welcome to our dedicated page for OMADA HEALTH SEC filings (Ticker: OMDA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Omada Health, Inc. (Nasdaq: OMDA) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. As a virtual-first, between-visit healthcare provider focused on cardiometabolic and musculoskeletal conditions, Omada uses these filings to report on its financial condition, operations, and material events related to its digital chronic care platform.
Investors can review current reports on Form 8-K, which Omada uses to furnish press releases announcing quarterly results and other significant developments. For example, recent 8-K filings reference earnings press releases for periods in which the company reported revenue, member growth, and updates on its GLP-1-related offerings and AI capabilities. These current reports help readers connect headline financial and operational metrics to the underlying SEC record.
In addition to 8-Ks, Omada’s periodic reports on Form 10-Q and Form 10-K (accessible through the SEC and linked from this page when available) typically contain more detailed information on revenue composition, cost structure, research and development spending, and risks associated with its virtual care and GLP-1 programs. These filings are particularly relevant for understanding how Omada’s cardiometabolic and musculoskeletal programs, GLP-1 Care Tracks, and prescribing and medication management capabilities are reflected in its financial statements and risk disclosures.
Stock Titan enhances this information with AI-powered summaries that explain key points from lengthy filings, helping readers quickly identify sections related to Omada’s chronic care model, GLP-1 initiatives, and digital health operations. Users can also monitor updates to OMDA’s filings in near real time, including new 8-Ks, 10-Qs, 10-Ks, and other relevant forms, to follow how the company reports on its performance and material events over time.
Omada Health, Inc. President Wei-Li Shao sold shares in a planned open-market transaction. On April 8, 2026, Shao sold 2,829 shares of Omada Health Common Stock at a weighted average price of $12.7062 per share in an open-market sale. After this transaction, Shao directly owns 328,850 shares. The sale was made pursuant to a Rule 10b5-1 trading plan adopted on August 15, 2025, indicating the trade was pre-arranged rather than a discretionary market-timed decision.
Omada Health, Inc. director Jeryl L. Hilleman received an equity grant in the form of restricted stock units. The filing reports an acquisition of 1,544 shares of Common Stock at a stated price of $0.00 per share, classified as a grant or award rather than a market purchase.
The RSUs were granted under the company’s Non-Employee Director Compensation Program in lieu of cash retainer fees. Each RSU represents the right to receive one share of Common Stock upon settlement. After this award, Hilleman directly holds 14,338 shares of Omada Health common stock.
ROOT JONATHAN D reported acquisition or exercise transactions in this Form 4 filing.
Omada Health, Inc. director Jonathan D. Root received an equity award of 882 shares of Common Stock in the form of restricted stock units granted under the company’s Non-Employee Director Compensation Program in lieu of cash retainer fees. Each RSU represents one share of Common Stock, to be settled on a date chosen by the director under the program or as otherwise specified by the program. Following this grant, he directly holds 180,175 shares of Common Stock. This is a compensation-related award, not an open-market purchase.
Klapstein Julie D reported acquisition or exercise transactions in this Form 4 filing.
Omada Health, Inc. director Julie D. Klapstein received an award of 698 shares of Common Stock in the form of restricted stock units (RSUs). The RSUs were granted under the company’s Non-Employee Director Compensation Program in lieu of cash retainer fees and carry a grant price of $0.00 per share.
Each RSU represents the right to receive one share of Common Stock, with settlement to occur on a date selected by the director or as otherwise provided by the program. Following this compensatory grant, Klapstein’s direct holdings total 10,434 shares of Common Stock reported in this filing.
FETTER TREVOR reported acquisition or exercise transactions in this Form 4 filing.
Omada Health, Inc. director Trevor Fetter received a grant of 955 restricted stock units (RSUs) of Common Stock. The award was issued under the company’s Non-Employee Director Compensation Program in lieu of cash retainer fees and carries a grant price of $0.00 per share.
Each RSU represents one share of Common Stock to be settled on a date selected by the director or as otherwise provided by the program. Following this grant, he holds 12,651 shares directly. The filing also records a transfer of 111,200 shares from a limited liability company to a family trust where he is a trustee and beneficiary, bringing his indirect holdings to 111,200 shares.
Omada Health, Inc. Chief Financial Officer Steven L. Cook reported an open-market sale of 1,884 shares of common stock at $13.94 per share on March 13, 2026. The transaction was made under a Rule 10b5-1 trading plan adopted on August 15, 2025.
After this sale, Cook directly holds 200,512 shares of Omada Health common stock. The sale represents a relatively small portion of his reported holdings and reflects a pre-planned trading arrangement rather than a discretionary trade.
Gracey Craig reported acquisition or exercise transactions in this Form 4 filing.
Omada Health Chief Accounting Officer Craig Gracey received a grant of 16,470 shares of Common Stock in the form of restricted stock units (RSUs). The award vests in 16 equal quarterly installments starting on March 1, 2026, with all RSUs fully vested on the fourth anniversary of that date.
Cook Steven L. reported acquisition or exercise transactions in this Form 4 filing.
Omada Health, Inc. reported that its Chief Financial Officer, Steven L. Cook, received a grant of 147,058 shares of Common Stock in the form of restricted stock units. After this award, he holds 202,396 shares directly. The RSUs vest in equal quarterly installments over four years starting from March 1, 2026.
Shao Wei-Li reported acquisition or exercise transactions in this Form 4 filing.
Omada Health, Inc. reported that President Wei-Li Shao received a grant of 264,705 restricted stock units (RSUs) of Common Stock at no purchase price. Each RSU represents the right to receive one share upon vesting. The award begins vesting on March 1, 2026, with 1/16 of the RSUs vesting on each quarterly anniversary, reaching full vesting on the fourth anniversary of that date. Following this grant, Shao directly holds 331,679 shares of Omada Health Common Stock.